keenan basu liu basu bock veldhuis logistic$$model glucose regulate peptide secretion hysteresis pathway disruption impaired fast glycemia physiol endocrinol metab publish june doi ajpendo analysis test hypothesis quantifiable$$disruption glucose stimulate insulin secretion dose response pathway mediate impaired fast glycemia ifg type diabetes mellitus adult normal impaired fast glycemia nfg ifg mixed$$meal glucose peptide glucose measure nfg ifg age body mass wavelet base deconvolution analysis estimate vary peptide secretion logistic$$dose response function analytically sensitivity potency efficacy pharmacological$$sense slope maximal$$stimulation maximal$$glucose stimulation prehepatic$$insulin peptide secretion hysteresis changepoint demarcate unequal$$glucose potency onset recovery pathway estimate accord nfg subject exhibit distinct$$onset recovery potency glucose stimulate peptide secretion vivo hysteresis potency shift ifg patient manifest glucose onset potency diminish peptide hysteretic$$shift patient markedly decrease glucose potency reversal peptide hysteretic$$shift lower peptide sensitivity glucose stimulation datum conclude dynamic$$dose response model glucose dependent$$control peptide secretion identify disruption vivo hysteresis patient ifg pathway analytic model aid prediabete biomarker
